{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:20:21Z","timestamp":1783092021248,"version":"3.54.6"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2019MB017"],"award-info":[{"award-number":["ZR2019MB017"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110034","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T15:04:10Z","timestamp":1779721450000},"page":"110034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of novel quinoline derivatives as selective HDAC6 inhibitors exhibiting multiple anticancer effects"],"prefix":"10.1016","volume":"179","author":[{"given":"Jie","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianlong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxia","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoqian","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingde","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7143","key":"10.1016\/j.bioorg.2026.110034_bb0005","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature05913","article-title":"Perceptions of epigenetics","volume":"447","author":"Bird","year":"2007","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bioorg.2026.110034_bb0010","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2174\/1568026615666150825141330","article-title":"Epigenetic alterations as a universal feature of Cancer hallmarks and a promising target for personalized treatments","volume":"16","author":"Schnekenburger","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110034_bb0015","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nmeth.2116","article-title":"Writing the histone code","volume":"9","author":"Rusk","year":"2012","journal-title":"Nat. Methods"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110034_bb0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cytogfr.2012.08.002","article-title":"The HAT\/HDAC interplay: multilevel control of STAT signaling","volume":"23","author":"Icardi","year":"2012","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bioorg.2026.110034_bb0025","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family","volume":"370","author":"De Ruijter","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2026.110034_bb0030","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ejmech.2018.08.081","article-title":"HDAC3 is a potential validated target for cancer: an overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR\/QSAR\/QAAR approaches","volume":"157","author":"Adhikari","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110034_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116972","article-title":"HDAC8 as a target in drug discovery: function, structure and design","volume":"280","author":"Zhao","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110034_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113946","article-title":"Medicinal chemistry updates of novel HDACs inhibitors (2020 to present)","volume":"227","author":"He","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110034_bb0045","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0430973100","article-title":"Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation","volume":"100","author":"Haggarty","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110034_bb0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tcb.2008.04.003","article-title":"HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions","volume":"18","author":"Valenzuela-Fernandez","year":"2008","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110034_bb0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbrc.2005.12.144","article-title":"Characterization of the two catalytic domains in histone deacetylase 6","volume":"341","author":"Zou","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2026.110034_bb0060","first-page":"875824","article-title":"The role of HDAC6 in cancer","volume":"2011","author":"Aldana-Masangkay","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"issue":"23","key":"10.1016\/j.bioorg.2026.110034_bb0065","doi-asserted-by":"crossref","first-page":"8035","DOI":"10.1128\/MCB.21.23.8035-8044.2001","article-title":"Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways","volume":"21","author":"Seigneurin-Berny","year":"2001","journal-title":"Mol. Cell. Biol."},{"issue":"Pt 8","key":"10.1016\/j.bioorg.2026.110034_bb0070","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1242\/jcs.03431","article-title":"HDAC6 deacetylation of tubulin modulates dynamics of cellular adhesions","volume":"120","author":"Tran","year":"2007","journal-title":"J. Cell Sci."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110034_bb0075","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1111\/febs.70062","article-title":"Pharmacological manipulation of liver fibrosis progression using novel HDAC6 inhibitors","volume":"292","author":"Borrello","year":"2025","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110034_bb0080","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10637-025-01508-9","article-title":"HDAC6 inhibition through WT161 synergizes with temozolomide, induces apoptosis, reduces cell motility, and decreases \u03b2-catenin levels in glioblastoma cells","volume":"43","author":"Oliveira","year":"2025","journal-title":"Investig. New Drugs"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110034_bb0085","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.molcel.2007.05.033","article-title":"HDAC6 modulates cell motility by altering the acetylation level of cortactin","volume":"27","author":"Zhang","year":"2007","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110034_bb0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/0115680096332732241113053459","article-title":"HDAC6: tumor progression and beyond","volume":"26","author":"Oliveira-Silva","year":"2026","journal-title":"Curr. Cancer Drug Targets"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110034_bb0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molmed.2003.12.005","article-title":"Altered states: selectively drugging the Hsp90 cancer chaperone","volume":"10","author":"Workman","year":"2004","journal-title":"Trends Mol. Med."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110034_bb0100","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s00221-024-06858-z","article-title":"HDAC6 modulates the cognitive behavioral function and hippocampal tissue pathological changes of APP\/PS1 transgenic mice through HSP90-HSF1 pathway","volume":"242","author":"Wang","year":"2024","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.bioorg.2026.110034_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107818","article-title":"HDAC6 mediates tumorigenesis during mitosis and the development of targeted deactivating agents","volume":"153","author":"Peng","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110034_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2014.12.050","article-title":"Advances in targeted therapy for unresectable melanoma: new drugs and combinations","volume":"359","author":"Hao","year":"2015","journal-title":"Cancer Lett."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110034_bb0115","doi-asserted-by":"crossref","first-page":"21579","DOI":"10.18632\/oncotarget.15375","article-title":"Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways","volume":"8","author":"Basu","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110034_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055529","article-title":"HDAC6 deacetylase activity is required for hypoxia-induced Invadopodia formation and cell invasion","volume":"8","author":"Arsenault","year":"2013","journal-title":"PLoS One"},{"issue":"37","key":"10.1016\/j.bioorg.2026.110034_bb0125","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1038\/sj.onc.1210614","article-title":"HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination","volume":"26","author":"Boyault","year":"2007","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110034_bb0130","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.molcel.2005.04.021","article-title":"HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor","volume":"18","author":"Kovacs","year":"2005","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110034_bb0135","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1074\/jbc.M111.273730","article-title":"Protein aggregates are recruited to Aggresome by histone deacetylase 6 via unanchored ubiquitin C termini","volume":"287","author":"Ouyang","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110034_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cells9102237","article-title":"HDAC6 regulates radiosensitivity of non-small cell lung Cancer by promoting degradation of Chk1","volume":"9","author":"Moses","year":"2020","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.bioorg.2026.110034_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071601","article-title":"Apoptosis induction byHistone deacetylase inhibitors in Cancer cells: role of Ku70","volume":"20","author":"Gong","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110034_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30132793","article-title":"A novel HDAC6 inhibitor enhances the efficacy of paclitaxel against ovarian Cancer cells","volume":"30","author":"Chi","year":"2025","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110034_bb0155","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s13238-011-1015-4","article-title":"Microtubule-associated deacetylase HDAC6 promotes angiogenesis by regulating cell migration in an EB1-dependent manner","volume":"2","author":"Li","year":"2011","journal-title":"Protein Cell"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110034_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/cells13060490","article-title":"HDAC6 enhances endoglin expression through deacetylation of transcription factor SP1, potentiating BMP9-induced angiogenesis","volume":"13","author":"Sun","year":"2024","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110034_bb0165","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/mc.22345","article-title":"Downregulation of HDAC6 promotes angiogenesis in hepatocellular carcinoma cells and predicts poor prognosis in liver transplantation patients","volume":"55","author":"Lv","year":"2016","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bioorg.2026.110034_bb0170","article-title":"Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells","volume":"9","author":"Knox","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110034_bb0175","article-title":"Overcome the tumor immunotherapy resistance by combination of the HDAC6 inhibitors with antitumor immunomodulatory agents","volume":"109","author":"Khamis","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"45","key":"10.1016\/j.bioorg.2026.110034_bb0180","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1038\/s41388-018-0379-9","article-title":"Histone deacetylase 6 regulates the immunosuppressive properties of cancer-associated fibroblasts in breast cancer through the STAT3-COX2-dependent pathway","volume":"37","author":"Li","year":"2018","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110034_bb0185","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/acs.jmedchem.7b01404","article-title":"(N-Hydroxycarbonylbenylamino)quinolines as selective histone deacetylase 6 inhibitors suppress growth of multiple myeloma in vitro and in vivo","volume":"61","author":"Lee","year":"2018","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110034_bb0190","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1016\/j.arabjc.2016.10.009","article-title":"Comprehensive review on current developments of quinoline-based anticancer agents","volume":"12","author":"Jain","year":"2019","journal-title":"Arab. J. Chem."},{"issue":"28","key":"10.1016\/j.bioorg.2026.110034_bb0195","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.2174\/1568026619666181129141822","article-title":"Structure, functions and selective inhibitors of HDAC6","volume":"18","author":"Liang","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110034_bb0200","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1021\/acs.jmedchem.0c01922","article-title":"Unique molecular interaction with the histone deacetylase 6 catalytic tunnel: crystallographic and biological characterization of a model chemotype","volume":"64","author":"Olaoye","year":"2021","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110034_bb0205","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1021\/acsmedchemlett.9b00084","article-title":"Design, synthesis, and biological evaluation of 2,4-Imidazolinedione derivatives as HDAC6 isoform-selective inhibitors","volume":"10","author":"Liang","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"issue":"6887","key":"10.1016\/j.bioorg.2026.110034_bb0210","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110034_bb0215","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14605","article-title":"HTRA1 promotes EMT through the HDAC6\/ac-\u03b1-tubulin pathway in human GBM cells","volume":"30","author":"Zhao","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bioorg.2026.110034_bb0220","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.canlet.2017.01.033","article-title":"HDAC6 deacetylates p53 at lysines 381\/382 and differentially coordinates p53-induced apoptosis","volume":"391","author":"Ryu","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2026.110034_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117218","article-title":"Small molecules targeting HDAC6 for cancer treatment: current progress and novel strategies","volume":"178","author":"Huang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.110034_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216695","article-title":"Inhibiting autophagy enhanced mitotic catastrophe-mediated anticancer immune responses by regulating the cGAS-STING pathway","volume":"586","author":"Bai","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110034_bb0235","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-025-02322-9","article-title":"Phosphorylated IRF3 promotes GSDME-mediated pyroptosis through RIPK1\/FADD\/caspase-8 complex formation during mitotic arrest in ovarian cancer","volume":"23","author":"Gong","year":"2025","journal-title":"Cell Commun. Signal"},{"issue":"19","key":"10.1016\/j.bioorg.2026.110034_bb0240","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1038\/s44318-025-00532-y","article-title":"HDAC6-dependent deacetylation of SAE2 enhances SUMO1 conjugation for mitotic integrity","volume":"44","author":"Lanz","year":"2025","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110034_bb0245","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2042065","article-title":"Coupling the immunomodulatory properties of the HDAC6 inhibitor ACY241 with oxaliplatin promotes robust anti-tumor response in non-small cell lung cancer","volume":"11","author":"Bag","year":"2022","journal-title":"Oncoimmunology"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826005705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826005705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T14:54:08Z","timestamp":1783090448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826005705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":49,"alternative-id":["S0045206826005705"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110034","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of novel quinoline derivatives as selective HDAC6 inhibitors exhibiting multiple anticancer effects","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110034"}}